<?xml version="1.0" encoding="UTF-8"?>
<p id="par0150">In clinical and epidemiological situations, the detection of JEV RNA can provide an invaluable indication of infection. The sensitivity of this test is, to a large extent, limited by a combination of the short period of viremia, the relatively low concentration of virus in CSF, and the fragility of RNA. The introduction of highly sensitive point-of-care tests that may be used to analyze multiple body fluids in parallel would partly resolve these challenges. Recently, there have been significant developments in highly sensitive molecular point-of-care tests for flaviviruses, such as reverse transcription loop-mediated isothermal amplification (RT-LAMP), reverse transcription recombinase polymerase amplification (RT-RPA), nucleic acid sequence-based amplification (NASBA), transcription-mediated amplification (TMA), helicase-dependent amplification (HDA), and nicking enzyme amplification reaction (NEAR) (
 <xref rid="bib0120" ref-type="bibr">Calvert et al., 2017</xref>, 
 <xref rid="bib0275" ref-type="bibr">Ganguli et al., 2017</xref>, 
 <xref rid="bib0430" ref-type="bibr">Kurosaki et al., 2017</xref>, 
 <xref rid="bib0520" ref-type="bibr">Mauk et al., 2017</xref>, 
 <xref rid="bib0595" ref-type="bibr">Priye et al., 2017</xref>, 
 <xref rid="bib0860" ref-type="bibr">Yaren et al., 2018</xref>, 
 <xref rid="bib0165" ref-type="bibr">Castro et al., 2018</xref>, 
 <xref rid="bib0315" ref-type="bibr">Guo et al., 2018</xref>, 
 <xref rid="bib0395" ref-type="bibr">Kim et al., 2018a</xref>, 
 <xref rid="bib0425" ref-type="bibr">Kumar et al., 2018</xref>, 
 <xref rid="bib0490" ref-type="bibr">Lopez-Jimena et al., 2018</xref>, 
 <xref rid="bib0445" ref-type="bibr">Lamb et al., 2018</xref>, 
 <xref rid="bib0645" ref-type="bibr">Sabalza et al., 2018</xref>, 
 <xref rid="bib0725" ref-type="bibr">Song et al., 2018</xref>, 
 <xref rid="bib0880" ref-type="bibr">Zhao and Feng, 2019</xref>, 
 <xref rid="bib0005" ref-type="bibr">Abd et al., 2017</xref>, 
 <xref rid="bib0185" ref-type="bibr">Chan et al., 2018</xref>, 
 <xref rid="bib0735" ref-type="bibr">Tan et al., 2018</xref>, 
 <xref rid="bib0780" ref-type="bibr">Vasileva Wand et al., 2018</xref>, 
 <xref rid="bib0640" ref-type="bibr">Saa et al., 2018</xref>). Microfluidics, chips, paper-based devices, and biosensors are also being developed (
 <xref rid="bib0560" ref-type="bibr">Onyango et al., 2017</xref>, 
 <xref rid="bib0010" ref-type="bibr">Adegoke et al., 2017</xref>, 
 <xref rid="bib0015" ref-type="bibr">Afsahi et al., 2018</xref>, 
 <xref rid="bib0040" ref-type="bibr">Ariffin et al., 2018</xref>, 
 <xref rid="bib0795" ref-type="bibr">Wasik et al., 2017</xref>).
</p>
